Clinical trials
Glaucoma, Neovascular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 6 |
| Recruiting | 3 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 3 |
| Ain Shams University | 2 |
| Federal University of São Paulo | 2 |
| Prince of Songkla University | 2 |
| Ruijin Hospital | 2 |
| Siriraj Hospital | 2 |
| Wills Eye | 2 |
| Zhongnan Hospital | 2 |
| Asociación para Evitar la Ceguera en México | 1 |
| Cairo University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma, Neovascular | 38 |
| Glaucoma | 10 |
| Glaucoma, Open-Angle | 10 |
| Glaucoma, Angle-Closure | 7 |
| Diabetic Retinopathy | 5 |
| Retinal Vein Occlusion | 4 |
| Exfoliation Syndrome | 3 |
| Macular Edema | 2 |
| Carotid Stenosis | 1 |
| Choroidal Neovascularization | 1 |
Trials
Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.